Lipid dysregulation is a hallmark of aging, and changes in lipid metabolism are implicated in the pathogenesis of age-related diseases including DED.
16 The cholesterol transporters Niemann–Pick disease type C1 (NPC1), and Niemann–Pick disease type C2 (NPC2) are dysregulated in aging.
17–19 NPC1 is a transmembrane protein that mediates intracellular cholesterol trafficking, and NPC2 is a soluble protein that functions in egressing and recycling of lipoprotein-derived cholesterol.
20–22 Dysregulation of these enzymes is linked to lipid accumulation in atherosclerosis and age-related macular degeneration.
23,24 Cathepsins are lysosomal proteases that are involved in antigen processing during immune responses, degradation of proteases and chemokines for cellular homeostasis, autophagy, proliferation, and metastasis, among many other functions.
25–27 Essential for lysosomal function and catabolism, the cathepsin proteases are also linked to aging and lipid dysregulation. Increased cathepsins are documented in atherosclerotic lesions,
28,29 with cathepsin B, D, and L enriched in macrophage-derived foam cells localized in necrotic cores of lipid plaques.
30 Cathepsin L (CTSL) is specifically linked to macrophage function in lipid degradation.
31,32 Although in vitro and mice studies suggest a role for CTSL in the reduction of body weight gain and adipogenesis through fibronectin, insulin receptor, and insulin-like growth factor 1 receptor degradation,
33,34 little is known about its role in lipid metabolism and possible dysregulation of NPC1, NPC2, and CTSL in aged LGs.